SARCLISA (ISATUXIMAB-IRFC) — FDA Approval BLA761113 (SANOFI AVENTIS US)
SARCLISA (ISATUXIMAB-IRFC) — FDA Approval BLA761113 (SANOFI AVENTIS US) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SARCLISA; Active ingredients: ISATUXIMAB-IRFC; Application number: BLA761113.
| Brand name | SARCLISA |
|---|---|
| Active ingredients | ISATUXIMAB-IRFC |
| Application number | BLA761113 |
| Sponsor | SANOFI AVENTIS US |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20200302 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →